The Brain Tumour Program at the Montreal Neurological Institute and Hospital is one of the largest and most comprehensive brain tumour research and treatment programs in the country. It includes the Brain Tumour Research Centre, the Translational Neuro-Oncology Program and the interdisciplinary Clinical Neuro-Oncology Program.
Areas of research include, but are not limited to, uncovering fundamental regulatory mechanisms that govern brain cancer development, regulate brain cancer stem-cell self-renewal and differentiation, drive invasion, and lead to treatment resistance. All state-of-the-art technologies are available including next-generation genomic and epigenomic testing, computational biology approaches, cell-based assays for drug screening, patient-derived cranial xenograft modeling, and small animal imaging.
The Brain Tumour Research Centre is directly integrated with The Neuro, enabling interactions and collaborations with molecular, cellular, and developmental neuroscientists and research groups.
Integration with the translational and clinical neuro-oncology programs ensures the seamless transition of discoveries into novel therapeutics clinical trial testing.
Primary Group Members